|Event Name||SMi 2016 Superbugs & Superdrugs USA
Monday, November 14, 2016
Tuesday, November 15, 2016
Renaissance Woodbridge Hotel
|Cost||$499 - $1,899
Broadening horizons on the growing global threat of Antimicrobial resistance (AMR) for almost two decades at the sell-out Superbugs & Superdrugs conference in Europe, SMi is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA. This year’s show in Iselin, New Jersey, will play host to an audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.
With huge interest from leaders in the field including PAHO/WHO, BARDA, NIH, Pfizer, AstraZeneca, Janssen and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date.
The program will hone in on key topics such as public private partnerships, collaboration, R&D, scientific priorities for antibiotic discovery, novel antibacterial therapeutic approaches, antibiotic stewardship, rapid diagnostic tools, combination therapies, resistance prevention, plus much more!
Benefits of Attending
LEARN about progress in the development of National Action Plans with exclusive keynotes from PAHO/WHO, NIAID and BARDA
CURRENT STATUS: Receive progressive insight into innovative developments in big pharma with updates on drug discovery
FAST TO MARKET: Evaluate zoonotic link between animals and humans to target emerging infectious diseases
DRUG DISCOVERY: Enable antibiotic drug development through novel approaches in treating gram-negative infections
TARGETING MECHANISIMS: Restore antibiotic sensitivity in multi-drug resistance infections
PREPARE: Prepare for outbreaks with case study insight into new paradigms for prevention and industry collaboration
Who Should Attend
CEOs, Chiefs, VPs, Directors, Heads, Principals of:
or working in the area of superbugs and superdrugs from pharmaceutical, biotech and research organizations!